BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv Y, Han X, Xu XF, Ji Y, Zhou YH, Sun HC, Zhou J, Fan J, Lou WH, Huang C. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection. BMC Cancer 2019;19:335. [PMID: 30961559 DOI: 10.1186/s12885-019-5457-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bijelic L. Prognosis of Resected Neuroendocrine Metastases: A Complex Puzzle Can Only be Solved One Small Piece at a Time. Ann Surg Oncol 2020;27:3579-80. [PMID: 32436190 DOI: 10.1245/s10434-020-08625-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Søreide JA, Kvaløy JT, Lea D, Sandvik OM, Al-Saiddi M, Haslerud TM, Garresori H, Karlsen LN, Gudlaugsson E, Søreide K. The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study. Cancer Rep (Hoboken) 2021;:e1462. [PMID: 34105314 DOI: 10.1002/cnr2.1462] [Reference Citation Analysis]
3 Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029-1050. [PMID: 31738624 DOI: 10.1080/14737140.2019.1693893] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
4 Perrodin SF, Renzulli MM, Maurer MH, Kim-Fuchs C, Candinas D, Beldi G, Lachenmayer A. CAN MICROWAVE ABLATION BE AN ALTERNATIVE TO RESECTION FOR THE TREATMENT OF NEUROENDOCRINE LIVER METASTASES? Endocr Pract 2020;26:378-87. [PMID: 31859556 DOI: 10.4158/EP-2019-0394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Huang J, Liu B, Lin M, Zhang X, Zheng Y, Xie X, Xu M, Xie X. Ultrasound-guided percutaneous radiofrequency ablation in treatment of neuroendocrine tumor liver metastases:a single-center experience. International Journal of Hyperthermia 2022;39:497-503. [DOI: 10.1080/02656736.2022.2048094] [Reference Citation Analysis]
6 Xie S, Li L, Wang X, Li L. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Medicine (Baltimore) 2021;100:e24223. [PMID: 33466202 DOI: 10.1097/MD.0000000000024223] [Reference Citation Analysis]
7 Kiritani S, Arita J, Matsumura M, Nishioka Y, Kudo H, Ichida A, Ishizawa T, Akamatsu N, Kaneko J, Hasegawa K. Repeat hepatectomy for patients with recurrent neuroendocrine liver metastasis: Comparison with first hepatectomy. Surgery 2020;167:404-9. [DOI: 10.1016/j.surg.2019.08.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]